Search
Research outputs
Synthesis, in vitro and in silico Anticancer Evaluation of Novel Pyridin-2-yl Estra-1,3,5(10)-triene Derivatives
[2024]
Stevanović (Ilić) Milica Synthesis and DNase I inhibitory properties of new benzocyclobutane-2,5-diones
[2019]
Bondžić, Bojan Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents
[2025]
Beljkaš, Milan Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies [2022]
Bon, Corentin; Barbachowska, Magdalena; Đoković, Nemanja
Arimondo, Paola B;
Application of parallel artificial membrane permeability assay technique and chemometric modeling for blood–brain barrier permeability prediction of protein kinase inhibitors
[2024]
Jovanović, Milan Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate–pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P -glycoprotein
[2026]
Mosić, Mirjana The Zn(S-pr-thiosal)<inf>2</inf> complex attenuates murine breast cancer growth by inducing apoptosis and G1/S cell cycle arrest
[2020]
Benazic S.; Silconi Z.; Jevtovic A. Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies
[2022]
Milica Radan The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions [2018]
Zloh MireAnticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction. [2018]
Garcia, Catarina; Silva, Catarina Oliveira; Monteiro, Carlos M; Nicolai, Marisa; Viana, Ana; Andrade, Joana M; Barasoain, Isabel; Stanković, Tijana; Quintana, José; Hernández, Inmaculada;Filters
By type
- 11